The value of angiogenic therapy with intramyocardial administration of basic fibroblast growth factor to treat severe coronary artery disease.
Katayama
Yukihiro
Y
Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takaji
Kentaro
K
Shao
Zhan-Qiang
ZQ
Matsukawa
Mai
M
Kunitomo
Ryuji
R
Hagiwara
Shoichiro
S
Moriyama
Shuji
S
Kawasuji
Michio
M